BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21781160)

  • 1. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
    Seo J; Payne JR; Novo Matos J; Fong WW; Connolly DJ; Luis Fuentes V
    J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L; Kilkenny E; Ferasin H
    J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction].
    Kuijpers NW; Szatmári V
    Tijdschr Diergeneeskd; 2011 May; 136(5):326-31. PubMed ID: 21614848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats.
    Singh MK; Cocchiaro MF; Kittleson MD
    J Feline Med Surg; 2010 Dec; 12(12):942-7. PubMed ID: 21036088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
    Hsu A; Kittleson MD; Paling A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac biomarkers in hyperthyroid cats.
    Sangster JK; Panciera DL; Abbott JA; Zimmerman KC; Lantis AC
    J Vet Intern Med; 2014; 28(2):465-72. PubMed ID: 24350989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
    J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
    Jackson BL; Adin DB; Lehmkuhl LB
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S296-305. PubMed ID: 26776587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
    Hori Y; Fujimoto E; Nishikawa Y; Nakamura T
    J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.
    Borgeat K; Sherwood K; Payne JR; Luis Fuentes V; Connolly DJ
    J Vet Intern Med; 2014; 28(6):1731-7. PubMed ID: 25319115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
    Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
    J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.
    Pierce KV; Rush JE; Freeman LM; Cunningham SM; Yang VK
    J Vet Intern Med; 2017 May; 31(3):678-684. PubMed ID: 28370373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
    Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt PR
    J Hypertens; 2005 May; 23(5):1083-90. PubMed ID: 15834296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.
    MacDonald KA; Kittleson MD; Larson RF; Kass P; Klose T; Wisner ER
    J Vet Intern Med; 2006; 20(5):1093-105. PubMed ID: 17063701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
    Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin I in cats with hypertrophic cardiomyopathy.
    Connolly DJ; Cannata J; Boswood A; Archer J; Groves EA; Neiger R
    J Feline Med Surg; 2003 Aug; 5(4):209-16. PubMed ID: 12878148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.